dextrothyroxine has been researched along with imatinib mesylate in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Alves, P; Bota, S; Constantino, C; Maia, R | 1 |
| Rein, T | 1 |
| Chen, J; Cheng, Q; Fang, Z; Jia, Q; Zhao, G | 1 |
2 review(s) available for dextrothyroxine and imatinib mesylate
| Article | Year |
|---|---|
Harnessing autophagy to fight SARS-CoV-2: An update in view of recent drug development efforts.
Topics: Antidepressive Agents; Antiviral Agents; Artesunate; Autophagy; Chloroquine; COVID-19 Drug Treatment; Drug Development; Drug Repositioning; Endoplasmic Reticulum; Endosomes; Humans; Hydroxychloroquine; Imatinib Mesylate; Infliximab; Intracellular Membranes; Ivermectin; Macrolides; Middle East Respiratory Syndrome Coronavirus; Niclosamide; Pandemics; RNA, Viral; SARS-CoV-2; Virus Replication | 2022 |
Comparative efficacy and safety of pharmacological interventions for severe COVID-19 patients: An updated network meta-analysis of 48 randomized controlled trials.
Topics: Colchicine; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; COVID-19 Serotherapy; Doxycycline; Humans; Imatinib Mesylate; Immunization, Passive; Immunoglobulins, Intravenous; Interferon beta-1b; Ivermectin; Lopinavir; Methylprednisolone; Network Meta-Analysis; Pandemics; Pneumonia, Viral; Randomized Controlled Trials as Topic; Ritonavir | 2022 |
1 other study(ies) available for dextrothyroxine and imatinib mesylate
| Article | Year |
|---|---|
Hypereosinophilia and severe bone disease in an African child: an unexpected diagnosis.
Topics: Adrenal Cortex Hormones; Africa; Albendazole; Animals; Anthelmintics; Antiparasitic Agents; Bone Diseases; Child, Preschool; Drug Combinations; Female; Humans; Hypereosinophilic Syndrome; Imatinib Mesylate; Ivermectin; mRNA Cleavage and Polyadenylation Factors; Oncogene Proteins, Fusion; Protein Kinase Inhibitors; Rare Diseases; Receptor, Platelet-Derived Growth Factor alpha; Strongyloides stercoralis; Strongyloidiasis; Treatment Outcome | 2019 |